U.K. Pharmaceuticals & Biotech Insider-Bought Value Plays

SkinBioTherapeutics

Market Cap: UK£26.6m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.